• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

近期糖化血红蛋白值与 2 型糖尿病患者的死亡风险。基于人群的病例对照研究。

Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study.

机构信息

London School of Hygiene and Tropical Medicine, Department of Medical Statistics, London, United Kingdom.

出版信息

PLoS One. 2013 Jul 5;8(7):e68008. doi: 10.1371/journal.pone.0068008. Print 2013.

DOI:10.1371/journal.pone.0068008
PMID:23861845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3702542/
Abstract

This study aimed to evaluate mortality within 365 days of HbA1c values of <6.5% or >9.0% in participants with clinical type 2 diabetes mellitus. A matched nested case-control study was implemented, within a cohort of participants with type 2 diabetes from 2000 to 2008. Conditional logistic regression was used to model the odds ratio for mortality adjusting for comorbidity and drug utilisation. There were 97,450 participants with type 2 diabetes; 16,585 cases that died during follow up were matched to 16,585 controls. The most recent HbA1c value was <6.5% (48 mmol/mol) for 22.2% of cases and 24.2% of controls, the HbA1c was >9.0% for 9.0% of cases and 7.7% of controls. In a complete case analysis, the adjusted odds ratio (AOR) for mortality associated with most recent HbA1c <6.5% was 1.31 (95% confidence interval (CI): 1.21,1.42). After multiple imputation of missing HbA1c values the AOR was 1.20 (CI: 1.12,1.28). The complete case analysis gave an AOR for HbA1c >9.0% of 1.51 (CI: 1.33, 1.70), in the multiple imputation analysis this was 1.29 (1.17,1.41). The risk associated with HbA1c <6.5% was age dependent. In the multiple imputation analysis the AOR was 1.53 (CI: 0.84 to 2.79) at age<55 years but 1.04 (CI: 0.92, 1.17) at age 85 years and over. In non-randomised data, values of HbA1c that are either <6.5% or >9.0% may be associated with increased mortality within one year in clinical type 2 diabetes. Relative risks may be higher at younger ages.

摘要

本研究旨在评估临床 2 型糖尿病患者的糖化血红蛋白(HbA1c)值<6.5%或>9.0%时的 365 天内死亡率。在 2000 年至 2008 年间,对 2 型糖尿病患者进行了一项匹配嵌套病例对照研究。采用条件逻辑回归模型,在调整合并症和药物使用的情况下,对死亡率的比值比进行建模。共有 97450 名 2 型糖尿病患者;在随访期间,有 16585 例死亡病例与 16585 例对照病例相匹配。最近的 HbA1c 值<6.5%(48mmol/mol)的病例占 22.2%,对照病例占 24.2%,HbA1c 值>9.0%的病例占 9.0%,对照病例占 7.7%。在完整病例分析中,与最近的 HbA1c 值<6.5%相关的死亡率调整比值比(AOR)为 1.31(95%置信区间(CI):1.21,1.42)。在缺失的 HbA1c 值进行多次插补后,AOR 为 1.20(CI:1.12,1.28)。完整病例分析得出的 HbA1c 值>9.0%的 AOR 为 1.51(CI:1.33,1.70),在多次插补分析中,这一数字为 1.29(1.17,1.41)。HbA1c 值<6.5%与年龄相关。在多次插补分析中,AOR 为 55 岁以下年龄组为 1.53(CI:0.84,2.79),85 岁及以上年龄组为 1.04(CI:0.92,1.17)。在非随机数据中,HbA1c 值<6.5%或>9.0%可能与临床 2 型糖尿病患者一年内的死亡率增加相关。相对风险在较年轻时可能更高。

相似文献

1
Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study.近期糖化血红蛋白值与 2 型糖尿病患者的死亡风险。基于人群的病例对照研究。
PLoS One. 2013 Jul 5;8(7):e68008. doi: 10.1371/journal.pone.0068008. Print 2013.
2
Mean HbA, HbA variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study.70 岁及以上糖尿病患者的平均 HbA、HbA 变异性和死亡率:一项回顾性队列研究。
Lancet Diabetes Endocrinol. 2018 Jun;6(6):476-486. doi: 10.1016/S2213-8587(18)30048-2. Epub 2018 Apr 16.
3
Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.糖尿病病程对老年 2 型糖尿病患者血糖控制与死亡风险关系的影响。
Diabetes Obes Metab. 2020 Feb;22(2):231-242. doi: 10.1111/dom.13891. Epub 2019 Nov 18.
4
Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.2 型糖尿病与英国普通心力衰竭人群全因住院和死亡的相关性:按糖尿病血糖控制和药物强化分层。
JACC Heart Fail. 2018 Jan;6(1):18-26. doi: 10.1016/j.jchf.2017.08.020. Epub 2017 Oct 11.
5
Epidemiology of type 2 diabetes remission in Scotland in 2019: A cross-sectional population-based study.2019 年苏格兰 2 型糖尿病缓解的流行病学:一项基于人群的横断面研究。
PLoS Med. 2021 Nov 2;18(11):e1003828. doi: 10.1371/journal.pmed.1003828. eCollection 2021 Nov.
6
Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol.80岁及以上2型糖尿病患者的死亡率与糖化血红蛋白、血压和总胆固醇的关系
J Am Geriatr Soc. 2016 Jul;64(7):1425-31. doi: 10.1111/jgs.14215. Epub 2016 Jun 13.
7
Impact of type 1 diabetes on maternal long-term risk of hospitalisation and mortality: a nationwide combined clinical and register-based cohort study (The EPICOM study).1 型糖尿病对产妇长期住院和死亡风险的影响:一项全国性的临床与登记注册相结合的队列研究(EPICOM 研究)。
Diabetologia. 2018 May;61(5):1071-1080. doi: 10.1007/s00125-018-4575-5. Epub 2018 Feb 24.
8
Association between hemoglobin A1c and all-cause mortality: results of the mortality follow-up of the German National Health Interview and Examination Survey 1998.糖化血红蛋白与全因死亡率的关系:1998 年德国国家健康访谈和体检调查死亡率随访结果。
Diabetes Care. 2015 Feb;38(2):249-56. doi: 10.2337/dc14-1787. Epub 2014 Nov 20.
9
Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study.在一个多民族且社会经济背景多样的人群中,根据诊断时糖化血红蛋白水平观察糖尿病初诊时及一年后的并发症情况:南伦敦糖尿病研究结果
J Diabetes Res. 2015;2015:587673. doi: 10.1155/2015/587673. Epub 2015 May 18.
10
BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.体重指数和糖化血红蛋白是胰腺癌的代谢标志物:使用英国初级保健数据库进行的匹配病例对照研究。
PLoS One. 2022 Oct 5;17(10):e0275369. doi: 10.1371/journal.pone.0275369. eCollection 2022.

引用本文的文献

1
Availability and affordability of antidiabetic medicines in Herat of Afghanistan in 2023.2023年阿富汗赫拉特地区抗糖尿病药物的可及性与可负担性
J Diabetes Metab Disord. 2024 Jun 14;23(2):1929-1940. doi: 10.1007/s40200-024-01444-0. eCollection 2024 Dec.
2
Impact of type 2 diabetes and microvascular complications on mortality and cardiovascular outcomes in a multiethnic Asian population.2 型糖尿病及微血管并发症对多民族亚洲人群死亡率及心血管结局的影响。
BMJ Open Diabetes Res Care. 2021 Jul;9(1). doi: 10.1136/bmjdrc-2020-001413.
3
Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth.经远程医疗强化药物治疗管理服务后糖化血红蛋白治疗结局评估。
Int J Environ Res Public Health. 2021 Jun 18;18(12):6560. doi: 10.3390/ijerph18126560.
4
Relationship between a single measurement at baseline of body mass index, glycated hemoglobin, and the risk of mortality and cardiovascular morbidity in type 2 diabetes mellitus.2型糖尿病患者基线时体重指数、糖化血红蛋白单次测量值与死亡风险及心血管疾病发病率之间的关系。
Cardiovasc Endocrinol Metab. 2020 May 25;9(4):177-182. doi: 10.1097/XCE.0000000000000202. eCollection 2020 Dec.
5
Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study.糖尿病与特定病因死亡率:一项基于人群的研究。
Diabetes Metab J. 2019 Jun;43(3):319-341. doi: 10.4093/dmj.2018.0060.
6
Association of Low Fasting Glucose and HbA1c With Cardiovascular Disease and Mortality: The MESA Study.空腹血糖及糖化血红蛋白水平与心血管疾病及死亡率的关联:多民族动脉粥样硬化研究(MESA)
J Endocr Soc. 2019 Mar 1;3(5):892-901. doi: 10.1210/js.2019-00033. eCollection 2019 May 1.
7
Blood Glucose Level Prediction for Diabetics Based on Nutrition and Insulin Administration Logs Using Personalized Mathematical Models.基于个性化数学模型的糖尿病患者营养和胰岛素使用日志的血糖水平预测。
J Healthc Eng. 2019 Jan 10;2019:8605206. doi: 10.1155/2019/8605206. eCollection 2019.
8
Albumin Abundance and Its Glycation Status Determine Hemoglobin Glycation.白蛋白丰度及其糖基化状态决定血红蛋白糖基化。
ACS Omega. 2018 Oct 31;3(10):12999-13008. doi: 10.1021/acsomega.8b01702. Epub 2018 Oct 10.
9
Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites.2 型糖尿病、糖化血红蛋白与肝功能失代偿合并腹水患者自发性细菌性腹膜炎风险的关系。
Clin Transl Gastroenterol. 2018 Sep 24;9(9):189. doi: 10.1038/s41424-018-0053-0.
10
Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study.2型糖尿病和慢性肾脏病的多重危险因素控制、死亡率及心血管事件:一项基于人群的队列研究
BMJ Open. 2018 May 8;8(5):e019950. doi: 10.1136/bmjopen-2017-019950.

本文引用的文献

1
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes.在 2 型糖尿病中,胰岛素与其他抗高血糖药物治疗的死亡率和其他重要的糖尿病相关结局。
J Clin Endocrinol Metab. 2013 Feb;98(2):668-77. doi: 10.1210/jc.2012-3042. Epub 2013 Jan 31.
2
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies.磺酰脲类药物治疗与全因和心血管死亡率的关联:观察性研究的系统评价和荟萃分析。
Diab Vasc Dis Res. 2013 Jul;10(4):302-14. doi: 10.1177/1479164112465442. Epub 2013 Jan 4.
3
DPP-4 inhibitors and lipids: systematic review and meta-analysis.DPP-4 抑制剂与血脂:系统评价和荟萃分析。
Adv Ther. 2012 Jan;29(1):14-25. doi: 10.1007/s12325-011-0088-z. Epub 2011 Dec 22.
4
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.糖化血红蛋白水平与 2 型糖尿病患者血管并发症和死亡的关系:血糖阈值的证据。
Diabetologia. 2012 Mar;55(3):636-43. doi: 10.1007/s00125-011-2404-1. Epub 2011 Dec 21.
5
Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.强化血糖控制对 2 型糖尿病患者的影响:随机临床试验的系统评价和试验序贯分析。
BMJ. 2011 Nov 24;343:d6898. doi: 10.1136/bmj.d6898.
6
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials.强化血糖降低治疗对 2 型糖尿病患者全因死亡率、心血管死亡和微血管事件的影响:随机对照试验的荟萃分析。
BMJ. 2011 Jul 26;343:d4169. doi: 10.1136/bmj.d4169.
7
Categories of glucose tolerance and continuous glycemic measures and mortality.血糖耐受分类和连续血糖指标与死亡率。
Eur J Epidemiol. 2011 Aug;26(8):637-45. doi: 10.1007/s10654-011-9609-y. Epub 2011 Jul 23.
8
Hemoglobin A1c predicts healing rate in diabetic wounds.糖化血红蛋白可预测糖尿病伤口的愈合速度。
J Invest Dermatol. 2011 Oct;131(10):2121-7. doi: 10.1038/jid.2011.176. Epub 2011 Jun 23.
9
Summary of revisions to the 2011 clinical practice recommendations.2011年临床实践建议修订摘要。
Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S3. doi: 10.2337/dc11-S003.
10
Severe hypoglycemia and risks of vascular events and death.严重低血糖与血管事件和死亡风险。
N Engl J Med. 2010 Oct 7;363(15):1410-8. doi: 10.1056/NEJMoa1003795.